Study Habits Sample Clauses

Study Habits. Other preferences: When one of us is studying, we prefer: □ To remain in the room □ To study elsewhere □ Other: When one of us is studying, we prefer: □ Complete silence □ Low music □ TV □ Other: When one of us is studying, the other(s) may: □ Watch TV □ Listen to music □ Use hair dryer □ Have guests over □ Have lights on □ Have a lamp on □ Talk on the phone □ Other:
AutoNDA by SimpleDocs
Study Habits. Preferred time for study: ______Morning ______During Day _____Night _______When I have time I prefer to study: _____In Room _____Outside of Room Room Conditions During Study Time This is OK This is Not OK Music Playing TV On Having guests in room _____ I must have complete quiet while studying If roommate is studying with a group: _____Can bring group to room ____Prefer they go elsewhere
Study Habits. What type of environment do you need to study effectively (e.g., without distractions such as television and/or music)? How often do you plan on studying? Communication: The apartment members will share the following: Please circle all that apply How will messages be communicated? If a problem arises, we will approach each other by: Other important considerations: MP3 Player TV/DVD Player Video Game Equipment Movies Appliances Computer Food Dishes Kitchen Utensils Pots / Pans Refrigerator Other: P a g e 3 Roommate Questionnaire Room: Room:
Study Habits. What time do you like to study? (late at night, mornings, during the day) How do you like to study? (complete silence, music, TV) Quiet hours are from 10:00pm – 10:00am Sunday through Thursday and 12:00am to 10:00am Friday and Saturday. Are there any other times that you would like to set aside for quiet hours or study time? Can guests be present while studying?
Study Habits. If you prefer studying in your suite, where will you be studying? (Kitchen table, bedroom, living room). What time(s) do you like to study? (Morning vs. afternoon vs. evening vs. night) What is your preferred noise level for studying? _ Parties: Residents are welcome to host parties and socials in their suite/house. Please review the Residence Community Living Standards (RCLS) found in the Residence Handbook for specifics on topics related to parties. What constitutes a party vs. “hanging out” vs. having friends over? (Number of people, environment, noise level, social activities involved). Please note that any guests who do not live in your complex must be signed in at the front desk on Fridays and Saturdays after 9:00pm. How often do we like to host parties? Will we host parties? We will refer to the communication section of our Roommate Agreement to address issues regarding parties (guests, certain social activities, noise level, time frame/time of day or night, etc.)

Related to Study Habits

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Team Teaching Unit members participating in team teaching assignments will receive formula hour credit in proportion to the percentage of in-class involvement. When team-taught class sizes exceed the normal, the formula conditions specified in Section 4.3.3 shall apply.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Vaccinations Contractor understands, acknowledges, and agrees that, pursuant to Article II of the General Appropriations Act, none of the General Revenue Funds appropriated to the Department of State Health Services (DSHS) may be used for the purpose of promoting or advertising COVID-19 vaccinations in the 2024-25 biennium. It is also the intent of the legislature that to the extent allowed by federal law, any federal funds allocated to DSHS shall be expended for activities other than promoting or advertising COVID-19 vaccinations. Contractor represents and warrants that it is not ineligible, nor will it be ineligible during the term of this Contract, to receive appropriated funding pursuant to Article II.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Transporting Students Teachers shall not be required to transport a student in a private vehicle on behalf of the school.

  • Study Area The study area focused on the Bulk Power System in South-Eastern New York between Albany and New York City, and voltages underlying systems at 115 kV and above in the lower Xxxxxx Valley (Zones G, H & I). In the PSS™E power flow base case provided by NYISO, facilities rated at 115 kV and above in PSS™E designated areas 6 through 11 are monitored in the study. These areas are: • Capital District • Xxxxxx • Millwood • Xxxxxxxxx • Con Ed • Long Island

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

Time is Money Join Law Insider Premium to draft better contracts faster.